Search
Erythropac

Erythropac

erythromycin

Manufacturer:

Pacific Pharma (Korea)

Distributor:

AA Medical
Concise Prescribing Info
Contents
Erythromycin
Indications/Uses
Upper resp tract infections eg, tonsilitis, peritonsillar abscess, pharyngitis, laryngitis, sinusitis, secondary infections (influenza & common colds); lower resp tract infections eg, tonsilitis, acute & chronic bronchitis, pneumonia (lobar & primary atypical pneumonia, bronchopneumonia), bronchiectasis, Legionnaire's disease; ear infection eg, otitis media & externa mastoiditis; oral infections eg, gingivitis, Vincent's angina; ear infection eg, blepharitis; skin & soft tissue infection eg, boils & carbuncles, paronychia, abscesses, pustular acne, impetigo, cellulitis, erysipelas; GI infections eg, cholecystitis, staphylococcal enterocolitis. Pre- & post-op prophylaxis; operative trauma, burns, rheumatic fever. Other infections eg, osteomyelitis, urethritis, gonorrhea, syphilis, lymphogranuloma venereum, diphtheria, prostatitis, scarlet fever.
Click to view Erythropac detailed prescribing information
Dosage/Direction for Use
Adult & older childn Usual dose: 1 tab 4-6 hrly, increased to 4 g/day in unusually severe infections.
Click to view Erythropac detailed prescribing information
Overdosage
View Erythropac overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Concurrent use w/ astemizole, terfenadine, cisapride or pimozide. Concomitant use w/ ergotamine & dihydroergotamine.
Click to view Erythropac detailed prescribing information
Warnings
For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Erythropac detailed prescribing information
Special Precautions
Patients w/ myasthenia gravis. Interferes w/ fluorometric determination of urinary catecholamines. Concomitant use w/ lovastatin. Hepatic impairment.
Click to view Erythropac detailed prescribing information
Adverse Reactions
Nausea, abdominal discomfort, vomiting & diarrhea, reversible hearing loss, erythema multiforme.
Drug Interactions
Enhanced risk of cardiotoxicity, serious CV events (Torsades de pointes, other ventricular arrhythmias & cardiac arrest). Concomitant use w/ terfenadine may lead to death. Elevated levels of cisapride, pimozide & clarithromycin may result in QT prolongation & cardiac arrhythmias including ventricular tachycardia & fibrillation, Torsades de pointes. Acute ergot toxicity characterized by development of severe peripheral vasospasm & dysaesthesia has been associated w/ ergotamine & dihydroergotamine. Rhabdomyolysis w/ or w/o renal impairment w/ lovastatin.
Click to view Erythropac detailed prescribing information
Storage
View Erythropac storage conditions for details to ensure optimal shelf-life.
Description
View Erythropac description for details of the chemical structure and excipients (inactive components).
Action
View Erythropac mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Macrolides
ATC Classification
J01FA01 - erythromycin ; Belongs to the class of macrolides. Used in the systemic treatment of infections.
Presentation/Packing
Form
Erythropac FC tab 250 mg
Packing/Price
10 × 10's
Form
Erythropac FC tab 500 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in